Combination therapy for the treatment of ocular neovascular disorders

Details for Australian Patent Application No. 2004268614 (hide)

International Classifications

Event Publications

13 April 2006 PCT application entered the National Phase

PCT publication WO2005/020972 Priority application(s): WO2005/020972

1 November 2007 Assignment before Grant

(OSI) Eyetech, Inc. The application has been assigned to Ophthotech Corporation

2 July 2009 Amendment Made

The nature of the amendment is: Amend the priority details to delete 60/498,407 US 27 Aug 2003

24 June 2010 Application Accepted

Published as AU-B-2004268614

8 July 2010 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 10 Jun 2010. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

28 October 2010 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 10 Jun 2010

17 February 2011 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 13 Oct 2010. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

9 June 2011 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 13 Oct 2010

16 June 2011 Standard Patent Sealed

11 October 2012 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 24 Aug 2012 . Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.